
Just stating a fact that CDP's role as custodian services only.   I suggest that you call CDP if you think otherwise and update us here :)
 
 
hotokee ( Date: 15-Jun-2012 21:37) Posted:
|
I think Biosensors is subjected to too much control by BBs despite its seemingly cheap price.   Warrants do in fact become a factor on pricing because its will reflect on how its payment at the expiry date will be like. It is like when we are short, we would not like a price to rise, and vice versa if we are long, we would not like a price to fall.   For us being a small player, there is no effect on the market on what we do. The real effect will come from BBs buying or selling and their intent to bring about a direction. 
The issuer is Paribas (BNP) and CDP is the agent.   The understanding between agent and issuer is not known publicly.   Furthermore, price rise does not necessarily result from demand.   It can happen but not always.
hotokee ( Date: 15-Jun-2012 21:20) Posted:
|
You guessing or you from the CDP? You know there are nuts here and there even at the least expected place? Or maybe you didn't know. So many cases involving ignorance in everyday life.
shinka2 ( Date: 15-Jun-2012 18:41) Posted:
|
Issuers/writers of the warrants will from time to time hedge their positions which includes buying the shares of the underlying security if they find the market is against them.   The buying of the securities will then generate a demand situation, thus causing prices to rise.
 
shinka2 ( Date: 15-Jun-2012 18:37) Posted:
|
Ya, CDP's role as custodian services only.
Strike prices are different depending at which point in time that the warrants have been written.
 
dowcog ( Date: 15-Jun-2012 12:29) Posted:
|
The CDP in there is not the CDP we know..
But I dont really care.. lol
the interesting thing for me is not even why no put warrants..
that is another thing for another day..
the main thing is the prices relative to expiry:
120905 - $1.65 
121002 - 1.45
121002A -   1.7
121101 - 1.45
130702 - 1.2
you get a sense of what the warrant issuers' feel on bio prices.. lol
i maybe wrong.. but interesting..  interesting..

CDP does not trade in securities:
CDP is a designated clearing house regulated under the Securities and Futures Act (SFA) and its relevant subsidiary legislation. The CDP clearing rules and delivery versus payment (DVP) rules govern its operations, its admission requirements and the ongoing obligations of its members. |
 
dowcog ( Date: 15-Jun-2012 12:04) Posted:
|
very detailed..
keep it up..
Like++

Bopanha ( Date: 15-Jun-2012 11:53) Posted:
|
These are the structured warrants for Biosensors, the expiry dates are after the CW words (call warrants). :So far, no Put warrants can be found for Biosensors meaning no issuer dares to bet that Biosensors will Not go down..
Structured Warrants-Code-Strike-Exchange-Agent
BiosensoBPeCW121002-O9OW-$1.45-(Ratio 3:1)-CDP
BiosensoBPeCW121002A-P1SW-$1.70-(Ratio 3:1)-CDP
BiosensoBPeCW130702-QQ6W-$1.20-(Ratio 1:1)-CDP
BiosensoMBeCW120905-P2IW-$1.65-(Ratio 25:10)-MC SEC
BiosensoMBeCW121101-QD9W-$1.40-(Ratio 25:10)-MC SEC
We have to note that CDP or MC Securities could be the issuers or the proxies or plain agents acting on behalf of an undisclosed person/firm for the SWs. It would be good if they are just intermediaries as they have vested interests in share investors' interests as well, being regulatory bodies and security firm.
From the above, we can calculate the effective " dividends" for players on expiry dates..
Lets check the more appropriate ones,
For warrant buyers, this is how the payout after expiry dates goes:
O9OW:- Biosensors at $1.48 " wins" you a cheque of approx $10 per 1000 warrants from the " Agent" and for every additional 1 ct increase in Biosensors it is $3.33 per 1000 warrants
P1SW:-At $1.73 your bet wins $10 per 1000 warrants additional 1 ct rise is $3.33 per 1000 warrants.
QQ6W:- Ah, this is the big one. If Biosensors is at $1.21 your bet wins you $10 per 1,000 warrants, and any additional increase of 1 ct is additional $10. per 1,000 warrants. At $1.48 agent must pay out $247 per 1000 warrants at expiry date. This is real disincentive for banker. It can get bank-rupted if Biosensors go to $2.00 per share. Of course, not necessarily because bankers are too big to fail. But they will use bit of gun powder to resist.  That's why I think Tomique said after October, it might rise.  I also agree with this, but in this game, there is no certainty.  Cheers.
Opinion only and not a discouragement or encouragement to gamble or invest in shares or warrants. Lol.
Bionsensors and Cosco Corp underperformedthe market on Thursday
Singapore’s Straits Times Index(RIC: .FTSTI) went down 0.47% yesterday to close at 2,773.81. Althoughthe index fell 2 days in a row, it still trades above its 20 DMA. For abullish play, QL9W is a Jul OTM call with effective gearing of 11.6times. For bearish play, QM0W is a Jul OTM put with effective gearingof 10.5 times.
Biosensors (RIC: BIOS.SI) tumbled4.68% on Thursday to close at S$1.12, making it as one of the worse performanceshare in the market yesterday. The share had dropped to S$1.115 as itsday low, which is also the lowest level of this year. On chart, the sharewas further below its 10 DMA after the drop, for those who think it mightrebound after the drop happened last month QQ6W is a Jul OTM callwith effective gearing of xxx times.  Cosco Corp (RIC: COSC.SI),another under-performing share in the market yesterday, dropped 3.02%to close at S$0.965. On chart, the share was trading below its 10 DMA already,but it dropped further to its 20 DMA at S$0.963 yesterday. For those whothink the share could maintain above the 20 DMA, O9RW is a Sep OTMcall with effective gearing of xxx times.
 
Code          Underlying                    Type  Strike  Expiry Divisor Warrant Last Implied Volatility Effective Gearing
QQ6W    BIOSENSORS        Call      b1.2    02/07/2013                        10              .22054.              52.9
Ah, sifu is right...
    Most players short when it breaks down the support line, or they buy when it breaks out at resistance.
          But breakouts or breakdowns can also be caused by people exiting their positions thus cause a spike.
                If one can catch such a spike, it would be ideal, since the peak of a false breakout would be the
                      most  juicy and meaty point to enter a trade, which provides maximum gain...

iluvgambling ( Date: 14-Jun-2012 23:03) Posted:
|
OCBC Research-
Healthcare Sector: Still positive on general outlook
Under our Healthcare sector coverage, both Raffles Medical Group (RMG) and Biosensors International Group (BIG) continued to deliver healthy revenue and earnings growth during the recent 1QCY12 results period, although the former’s PATMI was slightly below our expectations. We expect BIG to continue its growth trajectory moving forward, despite price cuts of drug-eluting stents in some countries which would dampen BIG’s gross margins. While competitive and wage pressures are on the rise for RMG, we expect the group to continue to benefit from thriving industry fundamentals and see room for RMG to raise its ASPs given its competitive pricing vis-ŕ-vis its peers. Maintain  OVERWEIGHT  on the Healthcare sector, with BIG [BUY FV: S$1.88] remaining as our preferred pick. We believe its recent share price sell down is overdone, and current valuations compare favourably against its peers. We also reiterate our  BUYrating and S$2.58 fair value estimate on RMG.
Under our Healthcare sector coverage, both Raffles Medical Group (RMG) and Biosensors International Group (BIG) continued to deliver healthy revenue and earnings growth during the recent 1QCY12 results period, although the former’s PATMI was slightly below our expectations. We expect BIG to continue its growth trajectory moving forward, despite price cuts of drug-eluting stents in some countries which would dampen BIG’s gross margins. While competitive and wage pressures are on the rise for RMG, we expect the group to continue to benefit from thriving industry fundamentals and see room for RMG to raise its ASPs given its competitive pricing vis-ŕ-vis its peers. Maintain  OVERWEIGHT  on the Healthcare sector, with BIG [BUY FV: S$1.88] remaining as our preferred pick. We believe its recent share price sell down is overdone, and current valuations compare favourably against its peers. We also reiterate our  BUYrating and S$2.58 fair value estimate on RMG.
when 1.12 broke momentarily, many shortist kept throwing at 1.115 but it held ground and closed 1.12. i an only say shortist kena bluff liao. see it rebound strongly again tomorrow. :) you short at resistance, not at support. :p
Fundamentally, a good company with good revenues and profitability.   Approvals of the DES for sale in China and USA will bring in more revenues and profits.
Shortists are out there, taking opportunity to push down the price of the stock during this period of overall market uncertainty.  
Eventually, what gets shorted down will go up very sharply especially with a company that has good fundamentals and also ahead of others in technology.   According to experts, there should be a biotech boom in the coming years!!
On Thursday, Biosensors re-test the support at $1.12 and closed at $1.12 with HIGH volume of 13.56 million shares traded.
A falling window occurred (where the bottom of the previous shadow is above the top of the current shadow).  This usually implies a continuation of a bearish trend.  There have been 4 falling windows in the last 50 candles–this makes the current falling window even more bearish.
RSI & MACD are bearish as RSI trend downwards.
Important Resistance of Biosensors: $1.20
Immediate Support of Biosensors: $1.12
Currently prices are well below 20/50/100/200 days MA.
Prices ha    ..................      READ MORE
 
Bopanha - Thanks for the education. I can understand why Biosensors would issue (company) warrants, or a third-party financial institution offer such a derivative, but why would the CDP do that?
Anyway, based on Tomique's research below and assuming that the Big Boys are depressing the price below the $1.45 strike price expiring October 2012,  we can expect Biosensors to move up freely if there are no  market fears after October 2012, right?
Looking at Biosensors price chart, it's present price of $1.12 appears to be at last October's low when the Greek crisis struck fear in the market. Looks to me it could well be the same euro crisis market fears causing Biosensors' downtrend  rather than Big Boys manipulation. Who knows?
At any rate, I am down now $7,200 and based on what you guys say, I need to hang in there against the Big Boys until  the $1.20 warrants expire in July 2013 if necessary. Hopefully, Biosensors will continue to prosper and the Euro crisis won't depress the market too much.     

Tomique ( Date: 13-Jun-2012 12:03) Posted:
|
Lol... It's not a matter of how juicy...
  For any stock, I follow a very strict rule:- always short only at juicy peaks.
        Juicy peaks are usually determined on the chart itself. But most players 
              will only think of shorting when they see a stock has fallen or broken
                    down the support because that is their signal. As far as I know,
                          few use my approach, because many only buy instead of short
                                when the general feeling around is all bullish everywhere...

So how juicy have you shorted? I'm more familiar with long, short just play a bit for fun. 

iPunter ( Date: 14-Jun-2012 19:08) Posted:
|